Join Us for Epi One’s Final Investment Webinar – A Conversation with CEO Michael Marquardt and Chief Scientist & Founder Dr. Fang
As our StartEngine campaign enters its final weeks, we're excited to invite you to a special webinar event on November 26th at 4:30 PM Eastern Time. ...
Read More Epi One: Top Reasons to Invest Today
7 Reasons to Invest in Epi One: Transforming Cancer Detection Imagine a world where a simple test could detect cancer at its earliest stages, long before ...
Read More Webinar Recap: Transforming Lives Through Early Cancer Detection
At Epi One, we're on a mission to change the landscape of cancer detection. Our recent webinar, led by our CEO, Michael Marquardt, highlighted our commitment ...
Read More Market Opportunity with Epi One
Market Opportunity with Epi One We believe Epi One is at the vanguard of the rapidly evolving cancer diagnostics sector, presenting a unique investment prospect. Why ...
Read More $1 Million Raised from Equity Crowdfunding
We are incredibly excited and humbled to announce that Epi One has now surpassed the $1 million mark in our equity crowding campaign on StartEngine. Epi ...
Read More Scientific Breakthrough in the Lab
We are delighted to report that recent experiments have enabled us to identify biomarkers for lung, pancreatic, stomach and colon cancers. This means that, whereas to ...
Read More StartEngine Campaign Surpasses $500,000
We are thrilled to announce that following the launch of our equity crowdfunding campaign on StartEngine on May 20th, we have already exceeded $500,000 in investments. ...
Read More Equity Crowdfunding Campaign for Cancer Diagnosis Tools
We are excited to announce the launch of our equity crowdfunding campaign on StartEngine. This campaign offers individuals the unique opportunity to invest in and own ...
Read More Cancer Diagnosis Angel Investment Tops $1 million
As revealed on CityBiz this week, we are delighted to confirm that ahead of our upcoming launch on StartEngine we have raised $1 million in an ...
Read More Interested in Learning More?
Sign up for our Insider Waiting List
Join our journey toward a future where cancer diagnosis is faster, more accurate, and more accessible than ever before.